These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8994158)

  • 1. Good technologies gone bad: how and why the cost-effectiveness of a medical intervention changes for different populations.
    Phelps CE
    Med Decis Making; 1997; 17(1):107-17. PubMed ID: 8994158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies.
    Allen MW; Hendi P; Schwimmer J; Bassett L; Gambhir SS
    Q J Nucl Med; 2000 Jun; 44(2):168-85. PubMed ID: 10967626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, randomized trial of quantitative pretest probability to reduce unnecessary medical radiation exposure in emergency department patients with chest pain and dyspnea.
    Kline JA; Jones AE; Shapiro NI; Hernandez J; Hogg MM; Troyer J; Nelson RD
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):66-73. PubMed ID: 24275953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do you really need that test? Experts point to overuse of screening and diagnostic tests.
    Johns Hopkins Med Lett Health After 50; 2012 Aug; 24(7):4-5. PubMed ID: 23033556
    [No Abstract]   [Full Text] [Related]  

  • 6. Technology assessment for radiologists.
    Sunshine JH; Applegate KE
    Radiology; 2004 Feb; 230(2):309-14. PubMed ID: 14752174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need to reduce unnecessary use.
    Pyenson B; Fitch K
    Health Aff (Millwood); 2013 Mar; 32(3):631. PubMed ID: 23459747
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.
    Danese MD; Powe NR; Sawin CT; Ladenson PW
    JAMA; 1996 Jul 24-31; 276(4):285-92. PubMed ID: 8656540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Top 5" lists top $5 billion.
    Kale MS; Bishop TF; Federman AD; Keyhani S
    Arch Intern Med; 2011 Nov; 171(20):1856-8. PubMed ID: 21965814
    [No Abstract]   [Full Text] [Related]  

  • 10. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
    Oddone EZ; Cowper PA; Hamilton JD; Feussner JR
    Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should there be systematic screening of coronary heart disease in asymptomatic patients with risk factors alone? A decision analysis approach.
    Junod AF
    Diabetes Metab; 1998 Dec; 24(6):496-507. PubMed ID: 9932216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).
    Barton GR; Briggs AH; Fenwick EA
    Value Health; 2008; 11(5):886-97. PubMed ID: 18489513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. India must act to stem rise of unnecessary medical interventions, says World Bank.
    Travasso C
    BMJ; 2014 Aug; 349():g5084. PubMed ID: 25112572
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of medical technologies: a generalized ROC analysis.
    Sainfort F
    Med Decis Making; 1991; 11(3):208-20. PubMed ID: 1908934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of medical necessity and cost-effectiveness in making medical decisions.
    Glassman PA; Model KE; Kahan JP; Jacobson PD; Peabody JW
    Ann Intern Med; 1997 Jan; 126(2):152-6. PubMed ID: 9005750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral.
    Walensky RP; Weinstein MC; Smith HE; Freedberg KA; Paltiel AD
    Med Decis Making; 2005; 25(3):321-9. PubMed ID: 15951459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate use of the appropriate use criteria (AUC) as a guide for reimbursement.
    Feldman DN; Naidu SS; Duffy PL
    J Invasive Cardiol; 2014 Oct; 26(10):559-61. PubMed ID: 25274868
    [No Abstract]   [Full Text] [Related]  

  • 18. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.
    Qaseem A; Alguire P; Dallas P; Feinberg LE; Fitzgerald FT; Horwitch C; Humphrey L; LeBlond R; Moyer D; Wiese JG; Weinberger S
    Ann Intern Med; 2012 Jan; 156(2):147-9. PubMed ID: 22250146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-Consumer Medical Testing in the Era of Value-Based Care.
    Rockwell KL
    JAMA; 2017 Jun; 317(24):2485-2486. PubMed ID: 28542699
    [No Abstract]   [Full Text] [Related]  

  • 20. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
    Cooper NJ; Sutton AJ; Abrams KR
    Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.